1. The Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI) Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34+ Selected Grafts for Allogeneic Hematopoietic Cell Transplantation 
Pere Barba, MD, Ravin Ratan, Izaskun Ceberio, MD, Patrick Hilden, PhD, Molly Maloy, MS, Juliet N. Barker, MBBS, Hugo Castro- Malaspina, MD, Ann A. Jakubowski, PhD, MD, Guenther Koehne, MD, PhD, Esperanza Papadopoulos, MD, Doris M. Ponce, MD, Craig S. Sauter, MD, Marcel R.M. van den Brink, MD, PhD, James W. Young, MD, FACP, Scott Avecilla, MD, PhD, Richard Meagher, PhD, Sean M. Devlin, PhD, Richard J. O'Reilly, MD, Sergio A. Giralt, MD, Miguel-Angel Perales, MD 
Biology of Blood and Marrow Transplantation 
Volume 22, Issue 3, Pages S304-S305 (March 2016)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1 Probability of OS and CRFS.
Biology of Blood and Marrow Transplantation  , S304-S305DOI: ( /j.bbmt )
Copyright © Terms and Conditions

3. Figure 2
Cumulative incidence of NRM according to the HCT-CI and HCT-CI/age.
Biology of Blood and Marrow Transplantation  , S304-S305DOI: ( /j.bbmt )
Copyright © Terms and Conditions